Literature DB >> 6166246

Inhibition of hepatitis B virus deoxyribonucleic acid polymerase by the 5'-triphosphates of 9-beta-D-arabinofuranosyladenine and 1-beta-D-arabinofuranosylcytosine.

G Hess, W Arnold, K H Meyer zum Büschenfelde.   

Abstract

9-beta-D-Arabinofuranosyladenine (ara-A), 1-beta-D-arabinofuranosylcytosine (ara-C), and their 5'-triphosphates (ara-ATP and ara-CTP) were tested for ability to inhibit the hepatitis B virus (HBV)-associated deoxyribonucleic acid (DNA) polymerase. Ara-C did not inhibit the HBV DNA polymerase at the concentrations tested, ara-A did so by 50% at a concentration of 30 mM, with the inhibition noncompetitive with respect to deoxyadenosine 5-triphosphate (dATP). Ara-ATP and ara-CTP inhibited the DNA polymerase test competitively with respect to dATP and dCTP, respectively. Both compounds were also active after initiation of the DNA polymerase reaction. The inhibition caused by ara-ATP and ara-CTP was shown to be reversible, with no evidence that ara-ATP or ara-CTP was incorporated into the HBV DNA.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6166246      PMCID: PMC181355          DOI: 10.1128/AAC.19.1.44

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Penetration of mouse fibroblasts by the 5'-phosphate of 9-beta-D-arabinofuranosyladenine and incorporation of the nucleotide into DNA.

Authors:  W Plunkett; L Lapi; P J Ortiz; S S Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

2.  The lethality of some D-arabinosyl nucleotides to mouse fibroblasts.

Authors:  P J Ortiz; M J Manduka; S S Cohen
Journal:  Cancer Res       Date:  1972-07       Impact factor: 12.701

3.  Virus-like particles in serum of patients with Australia-antigen-associated hepatitis.

Authors:  D S Dane; C H Cameron; M Briggs
Journal:  Lancet       Date:  1970-04-04       Impact factor: 79.321

4.  DNA of a human hepatitis B virus candidate.

Authors:  W S Robinson; D A Clayton; R L Greenman
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

5.  Radioimmunoassay for the detection of the core of the Dane particle and antibody to it.

Authors:  R H Purcell; J L Gerin; J B Almeida; P V Holland
Journal:  Intervirology       Date:  1974       Impact factor: 1.763

6.  Inhibition of mammalian DNA polymerase by the 5'-triphosphate of 9-beta-D-arabinofuranosyladenine.

Authors:  J J Furth; S S Cohen
Journal:  Cancer Res       Date:  1967-09       Impact factor: 12.701

Review 7.  Introduction to the biochemistry of D-arabinosyl nucleosides.

Authors:  S S Cohen
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1966

8.  Antiviral activity of 9-beta-D-arabinofuranosyladenine. II. Activity against Herpes simplex keratitis in hamsters.

Authors:  R W Sidwell; G J Dixon; F M Schabel; D H Kaump
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

9.  In vivo antiviral properties of biologically active compounds. II. Studies with influenza and vaccinia viruses.

Authors:  R W Sidwell; G J Dixon; S M Sellers; F M Schabel
Journal:  Appl Microbiol       Date:  1968-02

10.  DNA polymerase associated with human hepatitis B antigen.

Authors:  P M Kaplan; R L Greenman; J L Gerin; R H Purcell; W S Robinson
Journal:  J Virol       Date:  1973-11       Impact factor: 5.103

View more
  3 in total

1.  Hepatitis-B virus-associated deoxyribonucleic acid polymerase: a partial characterization by the use of chemical agents.

Authors:  G Hess; W Arnold; K H Meyer zum Büschenfelde
Journal:  Klin Wochenschr       Date:  1981-06-15

2.  Comparison of properties of woodchuck hepatitis virus and human hepatitis B virus endogenous DNA polymerases.

Authors:  O Hantz; T Ooka; L Vitvitski; C Pichoud; C Trepo
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

3.  Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.

Authors:  Marion Gruffaz; Shenghua Zhou; Karthik Vasan; Teresa Rushing; Qing Liu Michael; Chu Lu; Jae U Jung; Shou-Jiang Gao
Journal:  MBio       Date:  2018-05-08       Impact factor: 7.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.